Literature DB >> 26996177

Endoplasmic Reticulum Stress and Bipolar Disorder - Almost Forgotten Therapeutic Drug Targets in the Unfolded Protein Response Pathway Revisited.

Susanne A Bengesser, Robert Fuchs, Nina Lackner, Armin Birner, Bernd Reininghaus, Nathalie Meier-Allard, Anika Stracke, Hans-Peter Kapfhammer, Eva Z Reininghaus1, Sandra Wallner-Liebmann.   

Abstract

Bipolar Disorder (BD) is characterized by recurring mood swings, which are not completely understood yet. So far, it is an accepted theory that multiple factors contribute to pathogenesis of BD according to the vulnerability-stressmodel. This model combines on the one hand biological predisposing vulnerability, and on the other hand several chronic and acute stressful negative events as underlying mechanisms of BD. Recently, ER (Endoplasmic Reticulum) stress reached the spotlight of BD research again. The expression of the chaperone BiP (syn. GRP78/glucose-regulated protein, 78kDa), which is highly expressed in the Endoplasmic Reticulum (ER), is upregulated by different kinds of mood stabilizers. These results implied that the ER, an organelle which is prone towards different kinds of cellular stress, might be involved in the pathophysiology of BD. This hypothesis was further strengthened by hypothesis driven genetic association studies, which showed significant association of BiP promotor polymorphisms with BD. Also other ER-stress associated genes like XBP1 (X-box binding protein 1) or GRP94 (glucose-regulated protein, 94kDa, synonym for heat shock protein HSP90B1) were recently linked to BD in hypothesis driven gene association studies. In addition to the proteins mentioned before, our review focuses on further UPR (Unfolded Protein Response) related proteins associated with BD and raises the hypothesis that ER-stress may represent a common interface between BD and obesity which is overrepresented in BD patients. Finally, members of the UPR pathway are discussed as putative targets for mood stabilizers.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26996177     DOI: 10.2174/1871527315666160321104613

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  7 in total

Review 1.  A review on shared clinical and molecular mechanisms between bipolar disorder and frontotemporal dementia.

Authors:  Camila Nascimento; Villela Paula Nunes; Roberta Diehl Rodriguez; Leonel Takada; Cláudia Kimie Suemoto; Lea Tenenholz Grinberg; Ricardo Nitrini; Beny Lafer
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-04-20       Impact factor: 5.067

2.  The diagnostic value of endoplasmic reticulum stress-related specific proteins GRP78 and CHOP in patients with sepsis: a diagnostic cohort study.

Authors:  Fangfang Li; Qionghua Lin; Lihua Shen; Zhongwei Zhang; Pengmei Wang; Shan Zhang; Qian Xing; Zhili Xia; Zhiyong Zhao; Yunhe Zhang; Biao Zhu
Journal:  Ann Transl Med       Date:  2022-04

Review 3.  Recent Insights into the Role of Unfolded Protein Response in ER Stress in Health and Disease.

Authors:  Dan Lindholm; Laura Korhonen; Ove Eriksson; Sulev Kõks
Journal:  Front Cell Dev Biol       Date:  2017-05-10

Review 4.  The Endoplasmic Reticulum Stress Response in Neuroprogressive Diseases: Emerging Pathophysiological Role and Translational Implications.

Authors:  Gerwyn Morris; Basant K Puri; Ken Walder; Michael Berk; Brendon Stubbs; Michael Maes; André F Carvalho
Journal:  Mol Neurobiol       Date:  2018-03-29       Impact factor: 5.590

Review 5.  Endoplasmic Reticulum Stress: Implications for Neuropsychiatric Disorders.

Authors:  Ather Muneer; Rana Mozammil Shamsher Khan
Journal:  Chonnam Med J       Date:  2019-01-25

Review 6.  Molecular Mechanisms Linking ALS/FTD and Psychiatric Disorders, the Potential Effects of Lithium.

Authors:  Fiona Limanaqi; Francesca Biagioni; Larisa Ryskalin; Carla L Busceti; Francesco Fornai
Journal:  Front Cell Neurosci       Date:  2019-10-04       Impact factor: 5.505

7.  Co-Expression Networks Unveiled Long Non-Coding RNAs as Molecular Targets of Drugs Used to Treat Bipolar Disorder.

Authors:  Trang Tt Truong; Chiara C Bortolasci; Briana Spolding; Bruna Panizzutti; Zoe Sj Liu; Srisaiyini Kidnapillai; Mark Richardson; Laura Gray; Craig M Smith; Olivia M Dean; Jee Hyun Kim; Michael Berk; Ken Walder
Journal:  Front Pharmacol       Date:  2022-04-08       Impact factor: 5.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.